FDA Approves Lilly’s Foundayo Oral GLP-1 Pill - Poll - MDSpire

FDA Approves Lilly’s Foundayo Oral GLP-1 Pill

The newly approved therapy offers a noninjectable option that can be taken at any time of day without food or water restrictions.

  • By

  • Kathryn Wighton

  • April 1, 2026

  • 2 min

Share

Original Source(s)

FDA Approves Lilly’s Foundayo Oral GLP-1 Pill

  • by Kathryn Wighton

  • April 1, 2026

Related Content

The role of lipid metabolism and creeping fat in disease assessment and prediction for Crohn’s disease

Lipidomics Point to Obesity–Alzheimer's Link

Study uses multi-omics tools to examine obesity-related pathways linked to neurodegeneration

  • May 26, 2026

  • 2 min
Impact of body mass index on outcomes of cardiac rehabilitation: a systematic review and meta-analysis